Ivan Hyep, Chief Financial Officer at Bicara Therapeutics Inc. (BCAX), sold 18,400 shares at $18.52 ($341K) on 2026-03-23, disclosed to the SEC on 2026-03-24.
Scheduled sale ($341k) by Chief Financial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $18.52 | 9,200 | $170K | 50.0% |
| 2 | $18.52 | 9,200 | $170K | 50.0% |
| Total | $18.52 avg | 18,400 | $341K | 100% |
| Filing → |
| BCAX | SELL | 2026-05-26 | $188K | — | Filing → |
| BCAX | SELL | 2026-04-22 | $212K | — | Filing → |
| BCAX | SELL | 2026-03-05 | $602K | — | Filing → |